{
    "eid": "2-s2.0-85131062927",
    "title": "ACUTE ENCEPHALOPATHY AFTER BNT162B2 COVID-19 VACCINATION: A CASE REPORT AND LITERATURE REVIEW",
    "cover-date": "2022-05-19",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "BNT162b2",
        "COVID-19 vaccine",
        "encephalopathy",
        "mRNA",
        "SLE"
    ],
    "authors": [
        "Hathairat Autjimanon",
        "Pongsakorn Champueng",
        "Ritthideach Yorsaeng",
        "Yong Poovorawan"
    ],
    "citedby-count": 0,
    "ref-count": 43,
    "ref-list": [
        "Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model",
        "Ten cases of systemic lupus erythematosus related to hepatitis B vaccine",
        "Encephalitis after vaccination in United States",
        "Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: a case report",
        "2019 European League against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus",
        "New-onset systemic lupus erythematosus after mRNA SARS-CoV-2 vaccination",
        "Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine",
        "A case of acute encephalopathy and non-ST segment elevation myocardial infarction following mRNA-1273 vaccination: possible adverse effect?",
        "In adults, the Oxford/ AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose",
        "BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting",
        "Subacute cutaneous lupus erythematosus triggered after measles vaccination",
        "Prompt onset of Rowell\u2019s syndrome following the first BNT162b2 SARS-CoV-2 vaccination",
        "Vaccines and neuroinflammation",
        "ANA Investigates: neurological complications of COVID-19 vaccines",
        "A clinical approach to diagnosis of autoimmune encephalitis",
        "Safety of COVID-19 vaccines administered in the EU: should we be concerned?",
        "The how\u2019s and what\u2019s of vaccine reactogenicity",
        "Acute disseminated encephalomyelitis in a patient vaccinated against SARS-CoV-2",
        "Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series",
        "Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination",
        "Two cases of post-Moderna COVID-19 vaccine encephalopathy associated with nonconvulsive status epilepticus",
        "Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study",
        "Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study",
        "Acute disseminated encephalomyelitis-like presentation after an inactivated coronavirus vaccine",
        "Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine",
        "Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): update from the Advisory Committee on Immunization Practices-United States, July 2021",
        "Systemic lupus erythematosus following HPV immunization or infection?",
        "Type I interferon-mediated regulation of antiviral capabilities of neutrophils",
        "SARS-CoV-2 vaccines in patients with SLE",
        "COVID-19 vaccines: modes of immune activation and future challenges",
        "Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine",
        "Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study",
        "Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group",
        "Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination",
        "Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination",
        "Postvaccinal encephalitis after ChAdOx1 nCov-19"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Lopburi",
            "@id": "116351042",
            "affilname": "King Narai Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/116351042",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "101823394",
            "affilname": "Royal Society of Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101823394",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center for Excellence in Clinical Virology",
        "King Narai Hospital",
        "Chulalongkorn University"
    ]
}